<?xml version="1.0" encoding="UTF-8"?>
<p id="p0275">Currently, the large-scale practical deployment of the above-mentioned devices to combat the pandemic spread of COVID-19 will allow their advantages and disadvantages to be quickly determined, after which further development can be encouraged. More systems will emerge in the near future in the context of the COVID-19 pandemic, after which companies are likely to switch their interest to systems that are more viable from an economic perspective. As of July 7, 2020, there were 104 approved test kits and systems approved by the U.S. FDA for emergency use authorization, with the vast majority being based on a real-time RT-PCR technique with or without sample preparation [
 <xref rid="bib104" ref-type="bibr">104</xref>].
</p>
